![](https://medcitynews.com/wp-content/themes/medcitynews/dist/images/mcn.png)
Cigna chief medical officer says ‘gap of hopefulness’ separates FDA approval & reimbursement
Cost effectiveness and outcomes drive value for payers, Cigna‘s Chief Medical Officer Alan Muney said. While some medical device companies assume an FDA approval will mean a definite reimbursement nod from payers, these two forces drive a sometimes wrongheaded “gap of hopefulness” for the industry. (See his discussion of why device companies need to think […]